Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: A single-center study
International Journal of Nephrology and Renovascular Disease Aug 10, 2017
Gojaseni P, et al. – A single–center study was designed to investigate whether a prescription of low–dose cinacalcet on alternate days could be an option for treatment of secondary hyperparathyroidism (HPT). Initial treatment with cinacalcet 25 mg on alternate days had the potential to decrease serum parathyroid hormone (PTH) levels for the aforementioned disease condition.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries